Premium tier

Allergan Botox

The original. US-FDA approved since 1989. The most clinically-evidenced Botulinum Toxin Type A in the world.

Brand facts

Manufacturer
Allergan / AbbVie
Country of origin
United States
Active ingredient
Botulinum Toxin Type A (onabotulinumtoxinA)
Price at Waleerat
From ฿8,000 / area
Regulatory
US FDA, Thai FDA, Korea KFDA, EU CE Mark
Available at
Siam Square One · Ekamai

Why we carry Botox (Allergan)

Allergan (now AbbVie) Botox is the original botulinum-toxin product — FDA-approved in 1989 for ophthalmic use and 2002 for cosmetic use. Three decades of clinical evidence, the largest published safety dataset in aesthetic medicine, and the brand most physicians worldwide trained on.

At Waleerat Clinic we stock Allergan Botox for patients who specifically request the original brand or who prioritise the longest available clinical track record. The molecule is botulinum toxin Type A (onabotulinumtoxinA) — identical mechanism to Dysport and Xeomin, but with different complex-protein formulations that affect onset speed, diffusion pattern, and dose-conversion ratios.

Pricing tier: premium. ฿8,000 / area reflects the manufacturer's R&D + safety-evidence premium relative to Korean alternatives (Hutox, Neuronox) at ฿3,000–฿5,000. We discuss the clinical and budgetary trade-offs at consult — most patients land on Allergan or Dysport for the first treatment, then optimise based on their personal response.

At a glance

  • Manufacturer: Allergan / AbbVie (USA)
  • First FDA approval: 1989 (ophthalmic) · 2002 (cosmetic)
  • Regulatory: US FDA · Thai FDA · KFDA · EU CE Mark
  • Active ingredient: Botulinum Toxin Type A (onabotulinumtoxinA)
  • Typical onset: 3–7 days · Peak effect: 14 days
  • Duration: 3–4 months (range 2–5 depending on individual metabolism)
  • Best for: patients prioritising the longest clinical track record

Considering Botox (Allergan)?

Free consultation. Physician confirms anatomical match before recommending brand or dose. No deposit.